The developers of ENADA and ENADAlet stabilized NADH, were the first to identify the importance of NADH in cellular development and energy transmissions for all bodily functions and organs. They founded Menuco Corporation in 1995 and is a world-renowned biochemical researcher and Medical Director after having studied the biochemical connections with NADH.
NADH was discovered in 1905 and was found to be an essential co-factor or co-partner for all enzymes in the body, and therefore is commonly known as “coenzyme 1.” Since its discovery, more than one thousand different physiological functions of NADH have been detected and extensively described in all biochemistry textbooks. However, NADH was viewed as so unstable—reacting to even small amounts of exposure to heat, light, or humidity—that it could not be used therapeutically. This was the reason that NADH has not been widely discussed before.